Equities Analysts Offer Predictions for JANX FY2025 Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at Cantor Fitzgerald boosted their FY2025 earnings per share estimates for Janux Therapeutics in a note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will earn ($3.28) per share for the year, up from their previous […]
